Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT01598402
Eligibility Criteria:
Inclusion Criteria:
* Patients with LAHNC which will be treated with CRT as discussed by a multidisciplinary team (i.e. a head and neck surgeon, a medical oncologist, and a radiation oncologist). This can be CRT as primary treatment or postoperative CRT.
* Written informed consent
* Expected adequacy of follow-up
Exclusion Criteria:
* Patients with pneumonia within the last 14 days before start of CRT
* Patients with other infections within the last 14 days within the last 14 days before start of CRT
* Patients with use of maintenance antibiotics
* Patients with antibiotic treatment within the last 14 days before start of CRT
* Patients with an allergy on amoxicillin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01598402
Study Brief:
Protocol Section:
NCT01598402